John Berger
Concepts (323)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intensive Care Units, Pediatric | 30 | 2020 | 288 | 2.310 |
Why?
| | Heart Arrest | 18 | 2024 | 411 | 1.700 |
Why?
| | Cardiopulmonary Resuscitation | 13 | 2024 | 339 | 1.420 |
Why?
| | Cardiac Surgical Procedures | 7 | 2019 | 611 | 1.180 |
Why?
| | Critical Care | 13 | 2016 | 702 | 1.090 |
Why?
| | Critical Illness | 13 | 2021 | 900 | 0.840 |
Why?
| | Airway Extubation | 2 | 2015 | 60 | 0.800 |
Why?
| | Echocardiography | 3 | 2016 | 648 | 0.770 |
Why?
| | Heart Defects, Congenital | 9 | 2024 | 910 | 0.760 |
Why?
| | Respiratory Insufficiency | 4 | 2021 | 327 | 0.750 |
Why?
| | Infant | 50 | 2024 | 10091 | 0.720 |
Why?
| | Extracorporeal Membrane Oxygenation | 10 | 2019 | 390 | 0.700 |
Why?
| | Infant, Newborn | 37 | 2024 | 6465 | 0.690 |
Why?
| | Antihypertensive Agents | 2 | 2016 | 521 | 0.680 |
Why?
| | Child, Preschool | 47 | 2024 | 11868 | 0.630 |
Why?
| | Child | 58 | 2024 | 22740 | 0.590 |
Why?
| | Hospitals, Pediatric | 10 | 2020 | 558 | 0.580 |
Why?
| | Pulmonary Atresia | 2 | 2016 | 23 | 0.570 |
Why?
| | Heart Diseases | 5 | 2019 | 341 | 0.550 |
Why?
| | Coronary Care Units | 2 | 2016 | 27 | 0.550 |
Why?
| | Respiration, Artificial | 6 | 2022 | 714 | 0.540 |
Why?
| | Hypertension | 2 | 2016 | 1276 | 0.510 |
Why?
| | Patient Handoff | 1 | 2017 | 44 | 0.500 |
Why?
| | Spectroscopy, Near-Infrared | 2 | 2016 | 70 | 0.490 |
Why?
| | Hospital Mortality | 14 | 2020 | 1038 | 0.490 |
Why?
| | Hemodynamics | 5 | 2020 | 1118 | 0.470 |
Why?
| | Models, Psychological | 1 | 2017 | 294 | 0.460 |
Why?
| | Operating Rooms | 1 | 2017 | 144 | 0.450 |
Why?
| | DiGeorge Syndrome | 1 | 2015 | 35 | 0.450 |
Why?
| | Tetralogy of Fallot | 1 | 2015 | 78 | 0.430 |
Why?
| | Cardiovascular Agents | 1 | 2016 | 166 | 0.420 |
Why?
| | Hypoplastic Left Heart Syndrome | 1 | 2015 | 119 | 0.420 |
Why?
| | Patient Care Team | 3 | 2017 | 697 | 0.420 |
Why?
| | Point-of-Care Systems | 1 | 2016 | 189 | 0.410 |
Why?
| | Ventilator Weaning | 2 | 2013 | 40 | 0.400 |
Why?
| | Patient Admission | 2 | 2015 | 220 | 0.390 |
Why?
| | Delivery Rooms | 1 | 2013 | 10 | 0.380 |
Why?
| | Heart Transplantation | 3 | 2024 | 680 | 0.370 |
Why?
| | Adolescent | 39 | 2024 | 22577 | 0.370 |
Why?
| | Oximetry | 1 | 2013 | 125 | 0.360 |
Why?
| | Quality Improvement | 3 | 2018 | 1296 | 0.360 |
Why?
| | Tertiary Care Centers | 4 | 2017 | 195 | 0.350 |
Why?
| | Arterial Pressure | 4 | 2024 | 134 | 0.350 |
Why?
| | Hypertension, Pulmonary | 3 | 2022 | 1957 | 0.340 |
Why?
| | Postoperative Care | 1 | 2013 | 286 | 0.330 |
Why?
| | Humans | 77 | 2024 | 145783 | 0.330 |
Why?
| | Echocardiography, Doppler | 1 | 2011 | 115 | 0.320 |
Why?
| | Death | 4 | 2013 | 132 | 0.320 |
Why?
| | Ultrasonography, Prenatal | 1 | 2013 | 295 | 0.320 |
Why?
| | Decision Support Techniques | 2 | 2017 | 480 | 0.300 |
Why?
| | Prospective Studies | 21 | 2020 | 8078 | 0.290 |
Why?
| | Fontan Procedure | 2 | 2024 | 192 | 0.280 |
Why?
| | Thrombosis | 3 | 2018 | 400 | 0.280 |
Why?
| | Heart Massage | 2 | 2018 | 11 | 0.270 |
Why?
| | Pulmonary Artery | 4 | 2018 | 1129 | 0.270 |
Why?
| | ROC Curve | 5 | 2017 | 618 | 0.270 |
Why?
| | Hypothermia, Induced | 4 | 2018 | 96 | 0.260 |
Why?
| | Male | 46 | 2024 | 73011 | 0.260 |
Why?
| | Female | 47 | 2024 | 79045 | 0.250 |
Why?
| | Communication | 4 | 2017 | 977 | 0.240 |
Why?
| | Bronchopulmonary Dysplasia | 2 | 2022 | 420 | 0.240 |
Why?
| | Parents | 6 | 2016 | 1407 | 0.240 |
Why?
| | District of Columbia | 2 | 2015 | 38 | 0.230 |
Why?
| | Administration, Inhalation | 3 | 2022 | 571 | 0.220 |
Why?
| | Severity of Illness Index | 9 | 2018 | 2933 | 0.220 |
Why?
| | Graft Rejection | 2 | 2024 | 521 | 0.200 |
Why?
| | Retrospective Studies | 15 | 2024 | 17330 | 0.200 |
Why?
| | Grief | 3 | 2013 | 51 | 0.180 |
Why?
| | Blood Gas Analysis | 2 | 2020 | 82 | 0.180 |
Why?
| | Meconium Aspiration Syndrome | 1 | 2022 | 11 | 0.180 |
Why?
| | Myocardium | 2 | 2024 | 935 | 0.180 |
Why?
| | Tracheobronchomalacia | 1 | 2022 | 15 | 0.180 |
Why?
| | Nitric Oxide | 3 | 2022 | 892 | 0.170 |
Why?
| | Survival Analysis | 4 | 2017 | 1378 | 0.170 |
Why?
| | Hydrocortisone | 2 | 2014 | 298 | 0.160 |
Why?
| | Blood Pressure | 4 | 2020 | 1782 | 0.160 |
Why?
| | Hemorrhage | 2 | 2017 | 822 | 0.160 |
Why?
| | Algorithms | 3 | 2017 | 1851 | 0.160 |
Why?
| | Selenium | 4 | 2013 | 50 | 0.160 |
Why?
| | Coma | 2 | 2018 | 38 | 0.160 |
Why?
| | Postoperative Complications | 3 | 2018 | 2977 | 0.160 |
Why?
| | Cross Infection | 3 | 2013 | 260 | 0.150 |
Why?
| | Bradycardia | 1 | 2020 | 61 | 0.150 |
Why?
| | Hypercapnia | 1 | 2019 | 53 | 0.150 |
Why?
| | Brain Death | 1 | 2019 | 60 | 0.150 |
Why?
| | Pulmonary Ventilation | 1 | 2019 | 82 | 0.150 |
Why?
| | Neurocognitive Disorders | 1 | 2019 | 33 | 0.140 |
Why?
| | Immunocompromised Host | 2 | 2012 | 202 | 0.140 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2022 | 248 | 0.140 |
Why?
| | Hypoxia-Ischemia, Brain | 1 | 2019 | 50 | 0.140 |
Why?
| | Risk Adjustment | 1 | 2019 | 85 | 0.140 |
Why?
| | Treatment Outcome | 13 | 2024 | 11794 | 0.140 |
Why?
| | Length of Stay | 4 | 2018 | 1350 | 0.140 |
Why?
| | Tachycardia, Ectopic Atrial | 1 | 2017 | 4 | 0.130 |
Why?
| | Cardiac Catheterization | 2 | 2019 | 559 | 0.130 |
Why?
| | Logistic Models | 4 | 2019 | 2139 | 0.130 |
Why?
| | Age Factors | 4 | 2018 | 3346 | 0.130 |
Why?
| | Cardiopulmonary Bypass | 2 | 2018 | 219 | 0.130 |
Why?
| | Zinc | 4 | 2013 | 307 | 0.130 |
Why?
| | Premature Birth | 1 | 2021 | 390 | 0.130 |
Why?
| | Thromboxane B2 | 1 | 2016 | 23 | 0.120 |
Why?
| | Carbon Dioxide | 1 | 2018 | 227 | 0.120 |
Why?
| | Monitoring, Physiologic | 3 | 2018 | 289 | 0.120 |
Why?
| | von Willebrand Diseases | 1 | 2016 | 28 | 0.120 |
Why?
| | Enoxaparin | 1 | 2017 | 68 | 0.120 |
Why?
| | Guideline Adherence | 2 | 2018 | 587 | 0.120 |
Why?
| | Risk Factors | 8 | 2018 | 10919 | 0.120 |
Why?
| | Intensive Care Units | 4 | 2016 | 924 | 0.120 |
Why?
| | Dietary Supplements | 2 | 2012 | 584 | 0.120 |
Why?
| | Randomized Controlled Trials as Topic | 3 | 2013 | 1752 | 0.120 |
Why?
| | Platelet Activation | 1 | 2016 | 99 | 0.120 |
Why?
| | Thromboembolism | 1 | 2017 | 129 | 0.120 |
Why?
| | Sepsis | 3 | 2013 | 664 | 0.120 |
Why?
| | Cardiac Output, Low | 1 | 2016 | 53 | 0.120 |
Why?
| | Sildenafil Citrate | 1 | 2015 | 60 | 0.110 |
Why?
| | Phenylpropionates | 1 | 2015 | 27 | 0.110 |
Why?
| | Postoperative Hemorrhage | 1 | 2016 | 105 | 0.110 |
Why?
| | Reproducibility of Results | 4 | 2023 | 3418 | 0.110 |
Why?
| | Immune System Diseases | 1 | 2015 | 37 | 0.110 |
Why?
| | Pyridazines | 1 | 2015 | 57 | 0.110 |
Why?
| | Risk Assessment | 4 | 2018 | 3752 | 0.110 |
Why?
| | Quality Assurance, Health Care | 1 | 2017 | 342 | 0.110 |
Why?
| | Standard of Care | 1 | 2016 | 81 | 0.110 |
Why?
| | Unconsciousness | 1 | 2015 | 24 | 0.110 |
Why?
| | Nervous System Diseases | 1 | 2018 | 286 | 0.110 |
Why?
| | Thrombelastography | 1 | 2016 | 192 | 0.110 |
Why?
| | Abdomen | 1 | 2016 | 142 | 0.110 |
Why?
| | Cerebrovascular Circulation | 1 | 2017 | 290 | 0.110 |
Why?
| | Receptor, Melanocortin, Type 2 | 1 | 2014 | 1 | 0.110 |
Why?
| | Interprofessional Relations | 1 | 2017 | 276 | 0.110 |
Why?
| | Catheterization | 1 | 2015 | 184 | 0.110 |
Why?
| | Bereavement | 2 | 2013 | 71 | 0.110 |
Why?
| | Vascular Surgical Procedures | 1 | 2018 | 343 | 0.110 |
Why?
| | Hospital Rapid Response Team | 1 | 2014 | 20 | 0.110 |
Why?
| | Myocarditis | 2 | 2019 | 102 | 0.110 |
Why?
| | Morbidity | 1 | 2015 | 322 | 0.100 |
Why?
| | Stress, Physiological | 3 | 2013 | 443 | 0.100 |
Why?
| | Analgesics, Opioid | 3 | 2013 | 1154 | 0.100 |
Why?
| | Whooping Cough | 2 | 2011 | 55 | 0.100 |
Why?
| | Pediatrics | 5 | 2015 | 1125 | 0.100 |
Why?
| | Time Factors | 8 | 2018 | 7134 | 0.100 |
Why?
| | Congresses as Topic | 1 | 2015 | 224 | 0.100 |
Why?
| | Magnetic Resonance Imaging | 2 | 2023 | 3916 | 0.100 |
Why?
| | Abnormalities, Multiple | 1 | 2015 | 199 | 0.100 |
Why?
| | Inservice Training | 1 | 2014 | 118 | 0.100 |
Why?
| | Regional Blood Flow | 1 | 2016 | 514 | 0.100 |
Why?
| | Lactates | 1 | 2013 | 82 | 0.100 |
Why?
| | Young Adult | 6 | 2019 | 14254 | 0.100 |
Why?
| | Clinical Trials Data Monitoring Committees | 1 | 2013 | 3 | 0.100 |
Why?
| | Out-of-Hospital Cardiac Arrest | 1 | 2015 | 121 | 0.100 |
Why?
| | Early Termination of Clinical Trials | 1 | 2013 | 18 | 0.100 |
Why?
| | Child Development | 2 | 2017 | 483 | 0.100 |
Why?
| | Aspirin | 1 | 2016 | 406 | 0.100 |
Why?
| | Inpatients | 1 | 2017 | 553 | 0.100 |
Why?
| | Blood Platelets | 1 | 2016 | 379 | 0.100 |
Why?
| | Heart Failure | 2 | 2017 | 2326 | 0.100 |
Why?
| | Program Evaluation | 1 | 2017 | 944 | 0.090 |
Why?
| | Survival Rate | 5 | 2019 | 2094 | 0.090 |
Why?
| | Prolactin | 1 | 2013 | 87 | 0.090 |
Why?
| | Physicians | 2 | 2013 | 956 | 0.090 |
Why?
| | Research Design | 3 | 2016 | 1139 | 0.090 |
Why?
| | Professional-Family Relations | 2 | 2011 | 154 | 0.090 |
Why?
| | Research | 1 | 2016 | 431 | 0.090 |
Why?
| | Perioperative Care | 1 | 2014 | 231 | 0.090 |
Why?
| | Asthma | 3 | 2012 | 1797 | 0.090 |
Why?
| | Cognitive Dysfunction | 1 | 2018 | 468 | 0.090 |
Why?
| | Ultrafiltration | 1 | 2011 | 28 | 0.090 |
Why?
| | Professional Role | 1 | 2013 | 170 | 0.090 |
Why?
| | United States | 11 | 2019 | 16126 | 0.090 |
Why?
| | Morphine | 1 | 2013 | 169 | 0.090 |
Why?
| | Anticoagulants | 1 | 2017 | 748 | 0.090 |
Why?
| | Sulfonamides | 1 | 2015 | 583 | 0.090 |
Why?
| | Fentanyl | 1 | 2013 | 128 | 0.080 |
Why?
| | Societies, Medical | 1 | 2015 | 900 | 0.080 |
Why?
| | Patient Acceptance of Health Care | 1 | 2018 | 883 | 0.080 |
Why?
| | Cardiac Output | 1 | 2011 | 179 | 0.080 |
Why?
| | Patient Discharge | 4 | 2019 | 995 | 0.080 |
Why?
| | Cognition Disorders | 1 | 2014 | 544 | 0.080 |
Why?
| | Multivariate Analysis | 4 | 2018 | 1547 | 0.070 |
Why?
| | Gestational Age | 1 | 2013 | 990 | 0.070 |
Why?
| | Practice Patterns, Physicians' | 1 | 2017 | 1372 | 0.070 |
Why?
| | Diastole | 2 | 2019 | 146 | 0.070 |
Why?
| | Fetus | 1 | 2013 | 804 | 0.070 |
Why?
| | Substance Withdrawal Syndrome | 1 | 2010 | 185 | 0.070 |
Why?
| | Metoclopramide | 3 | 2013 | 20 | 0.070 |
Why?
| | Predictive Value of Tests | 2 | 2023 | 2123 | 0.060 |
Why?
| | Health Services Research | 1 | 2010 | 391 | 0.060 |
Why?
| | Brain | 2 | 2017 | 2969 | 0.060 |
Why?
| | Positive-Pressure Respiration | 2 | 2022 | 115 | 0.060 |
Why?
| | Glutamine | 3 | 2013 | 109 | 0.060 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2014 | 2181 | 0.060 |
Why?
| | Cooperative Behavior | 1 | 2010 | 463 | 0.060 |
Why?
| | Follow-Up Studies | 4 | 2019 | 5428 | 0.060 |
Why?
| | Lung | 2 | 2018 | 4116 | 0.060 |
Why?
| | Practice Guidelines as Topic | 3 | 2018 | 1582 | 0.060 |
Why?
| | Incidence | 3 | 2017 | 2934 | 0.060 |
Why?
| | Clinical Protocols | 2 | 2017 | 280 | 0.060 |
Why?
| | Cohort Studies | 5 | 2018 | 6033 | 0.060 |
Why?
| | Adaptation, Psychological | 1 | 2011 | 719 | 0.060 |
Why?
| | Pregnancy | 2 | 2021 | 7216 | 0.050 |
Why?
| | Glucocorticoids | 1 | 2009 | 532 | 0.050 |
Why?
| | Adult | 5 | 2016 | 40881 | 0.050 |
Why?
| | Pain | 1 | 2010 | 791 | 0.050 |
Why?
| | Breath Holding | 1 | 2023 | 10 | 0.050 |
Why?
| | Magnetic Resonance Imaging, Cine | 1 | 2024 | 214 | 0.050 |
Why?
| | Phantoms, Imaging | 1 | 2023 | 159 | 0.050 |
Why?
| | Natriuretic Peptide, Brain | 1 | 2022 | 109 | 0.040 |
Why?
| | Opioid-Related Disorders | 1 | 2010 | 605 | 0.040 |
Why?
| | Ventilators, Mechanical | 1 | 2022 | 71 | 0.040 |
Why?
| | Heart-Assist Devices | 2 | 2018 | 568 | 0.040 |
Why?
| | Biopsy | 1 | 2024 | 1082 | 0.040 |
Why?
| | Whey Proteins | 2 | 2012 | 9 | 0.040 |
Why?
| | Milk Proteins | 2 | 2012 | 33 | 0.040 |
Why?
| | Bronchoscopy | 1 | 2022 | 227 | 0.040 |
Why?
| | Reperfusion | 1 | 2020 | 54 | 0.040 |
Why?
| | Rocky Mountain Spotted Fever | 1 | 2019 | 2 | 0.040 |
Why?
| | Fibrosis | 1 | 2022 | 561 | 0.040 |
Why?
| | Capnography | 1 | 2019 | 15 | 0.040 |
Why?
| | Pupil Disorders | 1 | 2019 | 7 | 0.040 |
Why?
| | Heart | 1 | 2023 | 626 | 0.040 |
Why?
| | Vasodilator Agents | 1 | 2021 | 330 | 0.040 |
Why?
| | Cerebral Infarction | 1 | 2019 | 47 | 0.040 |
Why?
| | Apnea | 1 | 2019 | 26 | 0.040 |
Why?
| | Brain Edema | 1 | 2019 | 62 | 0.040 |
Why?
| | Systole | 1 | 2019 | 181 | 0.040 |
Why?
| | Tissue Donors | 1 | 2022 | 420 | 0.040 |
Why?
| | Hypotension | 1 | 2019 | 127 | 0.030 |
Why?
| | Kaplan-Meier Estimate | 2 | 2013 | 971 | 0.030 |
Why?
| | Glasgow Coma Scale | 1 | 2019 | 218 | 0.030 |
Why?
| | Tidal Volume | 1 | 2018 | 109 | 0.030 |
Why?
| | Interviews as Topic | 2 | 2013 | 916 | 0.030 |
Why?
| | Single-Blind Method | 1 | 2018 | 318 | 0.030 |
Why?
| | Blood Pressure Determination | 1 | 2018 | 145 | 0.030 |
Why?
| | Pressure | 1 | 2018 | 226 | 0.030 |
Why?
| | Registries | 2 | 2018 | 2410 | 0.030 |
Why?
| | Infant, Premature | 1 | 2022 | 620 | 0.030 |
Why?
| | Adolescent Development | 1 | 2017 | 72 | 0.030 |
Why?
| | Shock, Septic | 1 | 2019 | 227 | 0.030 |
Why?
| | Epinephrine | 1 | 2018 | 158 | 0.030 |
Why?
| | Injections, Subcutaneous | 1 | 2017 | 170 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2024 | 2968 | 0.030 |
Why?
| | Guidelines as Topic | 2 | 2011 | 268 | 0.030 |
Why?
| | Anti-Arrhythmia Agents | 1 | 2017 | 144 | 0.030 |
Why?
| | Vascular Resistance | 1 | 2018 | 370 | 0.030 |
Why?
| | Benchmarking | 1 | 2018 | 191 | 0.030 |
Why?
| | Collateral Circulation | 1 | 2016 | 20 | 0.030 |
Why?
| | Aortic Valve Stenosis | 1 | 2019 | 256 | 0.030 |
Why?
| | von Willebrand Factor | 1 | 2016 | 85 | 0.030 |
Why?
| | Lactic Acid | 1 | 2018 | 295 | 0.030 |
Why?
| | Infusions, Intravenous | 1 | 2017 | 428 | 0.030 |
Why?
| | Disability Evaluation | 1 | 2017 | 311 | 0.030 |
Why?
| | Heart Septal Defects, Ventricular | 1 | 2016 | 45 | 0.030 |
Why?
| | Treatment Failure | 1 | 2017 | 360 | 0.030 |
Why?
| | Body Temperature | 1 | 2017 | 227 | 0.030 |
Why?
| | Acidosis, Lactic | 1 | 2016 | 46 | 0.030 |
Why?
| | Hemolysis | 1 | 2017 | 242 | 0.030 |
Why?
| | Drug Administration Schedule | 1 | 2017 | 782 | 0.030 |
Why?
| | Receptors, Mineralocorticoid | 1 | 2014 | 11 | 0.030 |
Why?
| | Health Status Indicators | 1 | 2015 | 167 | 0.030 |
Why?
| | Burns | 1 | 2019 | 374 | 0.030 |
Why?
| | Patient Simulation | 1 | 2014 | 43 | 0.030 |
Why?
| | Electrocardiography | 1 | 2017 | 668 | 0.030 |
Why?
| | Hospitalization | 2 | 2017 | 2461 | 0.030 |
Why?
| | Clinical Decision-Making | 1 | 2017 | 364 | 0.030 |
Why?
| | Recovery of Function | 1 | 2017 | 716 | 0.020 |
Why?
| | Patient Safety | 1 | 2017 | 356 | 0.020 |
Why?
| | Medical Futility | 1 | 2013 | 32 | 0.020 |
Why?
| | Lymphopenia | 1 | 2013 | 62 | 0.020 |
Why?
| | Lymphocyte Count | 1 | 2013 | 165 | 0.020 |
Why?
| | Cardiology | 2 | 2006 | 362 | 0.020 |
Why?
| | Neuropsychological Tests | 1 | 2018 | 1137 | 0.020 |
Why?
| | Area Under Curve | 1 | 2013 | 332 | 0.020 |
Why?
| | Midazolam | 1 | 2013 | 73 | 0.020 |
Why?
| | Status Asthmaticus | 1 | 2012 | 13 | 0.020 |
Why?
| | Attitude to Death | 1 | 2013 | 76 | 0.020 |
Why?
| | Anesthesia, Inhalation | 1 | 2012 | 14 | 0.020 |
Why?
| | Respiratory Physiological Phenomena | 1 | 2012 | 35 | 0.020 |
Why?
| | Confidence Intervals | 1 | 2013 | 330 | 0.020 |
Why?
| | Evidence-Based Medicine | 1 | 2016 | 740 | 0.020 |
Why?
| | Centrifugation | 1 | 2011 | 28 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2022 | 2770 | 0.020 |
Why?
| | Alleles | 1 | 2014 | 896 | 0.020 |
Why?
| | Adrenal Cortex Hormones | 1 | 2014 | 484 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2019 | 3634 | 0.020 |
Why?
| | Models, Statistical | 1 | 2015 | 672 | 0.020 |
Why?
| | Oxygen | 1 | 2016 | 981 | 0.020 |
Why?
| | Immune Tolerance | 1 | 2013 | 385 | 0.020 |
Why?
| | Hypnotics and Sedatives | 1 | 2013 | 222 | 0.020 |
Why?
| | Prognosis | 1 | 2019 | 4330 | 0.020 |
Why?
| | Tachyphylaxis | 1 | 2010 | 4 | 0.020 |
Why?
| | Receptors, Opioid | 1 | 2010 | 21 | 0.020 |
Why?
| | Psychometrics | 1 | 2014 | 732 | 0.020 |
Why?
| | Odds Ratio | 1 | 2013 | 1083 | 0.020 |
Why?
| | Antibiotic Prophylaxis | 1 | 2011 | 134 | 0.020 |
Why?
| | Drug Tolerance | 1 | 2010 | 99 | 0.020 |
Why?
| | Infection Control | 1 | 2011 | 173 | 0.020 |
Why?
| | Anti-Asthmatic Agents | 1 | 2012 | 260 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2014 | 1217 | 0.020 |
Why?
| | Genotype | 1 | 2014 | 1857 | 0.020 |
Why?
| | Ethics, Research | 1 | 2009 | 31 | 0.020 |
Why?
| | Immunoglobulins, Intravenous | 1 | 2010 | 133 | 0.020 |
Why?
| | Intubation, Intratracheal | 1 | 2012 | 327 | 0.020 |
Why?
| | Pilot Projects | 1 | 2015 | 1898 | 0.020 |
Why?
| | Physician's Role | 1 | 2011 | 225 | 0.020 |
Why?
| | Uncertainty | 1 | 2009 | 146 | 0.020 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2010 | 533 | 0.020 |
Why?
| | Immune System | 1 | 2010 | 180 | 0.020 |
Why?
| | Regression Analysis | 1 | 2010 | 1001 | 0.020 |
Why?
| | Parenteral Nutrition | 1 | 2009 | 102 | 0.020 |
Why?
| | Data Collection | 1 | 2011 | 643 | 0.020 |
Why?
| | DNA | 1 | 2014 | 1437 | 0.020 |
Why?
| | Double-Blind Method | 1 | 2012 | 2064 | 0.020 |
Why?
| | Enteral Nutrition | 1 | 2009 | 217 | 0.020 |
Why?
| | Sex Factors | 1 | 2013 | 2110 | 0.020 |
Why?
| | Biomedical Research | 1 | 2013 | 719 | 0.010 |
Why?
| | Emergency Medical Services | 1 | 2013 | 684 | 0.010 |
Why?
| | Patient Readmission | 1 | 2012 | 773 | 0.010 |
Why?
| | Social Support | 1 | 2010 | 651 | 0.010 |
Why?
| | Drug Therapy, Combination | 1 | 2009 | 1043 | 0.010 |
Why?
| | Neurons | 1 | 2010 | 1652 | 0.010 |
Why?
| | Anti-Bacterial Agents | 1 | 2011 | 1925 | 0.010 |
Why?
| | Cross-Sectional Studies | 1 | 2010 | 5925 | 0.010 |
Why?
| | Middle Aged | 1 | 2011 | 36309 | 0.000 |
Why?
|
|
Berger's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|